Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1964 1
1965 2
1968 4
1969 3
1970 1
1971 4
1972 1
1973 3
1974 2
1975 6
1976 6
1977 8
1978 8
1979 8
1980 7
1981 6
1982 7
1983 11
1984 10
1985 12
1986 9
1987 8
1988 8
1989 7
1990 11
1991 5
1992 7
1993 10
1994 11
1995 9
1996 17
1997 10
1998 10
1999 6
2000 13
2001 20
2002 16
2003 10
2004 8
2005 7
2006 14
2007 20
2008 25
2009 10
2010 17
2011 15
2012 15
2013 26
2014 28
2015 35
2016 27
2017 29
2018 27
2019 29
2020 48
2021 51
2022 66
2023 71
2024 56
2025 26

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

863 results

Results by year

Filters applied: . Clear all
Page 1
How I treat warm autoimmune hemolytic anemia.
Barcellini W, Fattizzo B. Barcellini W, et al. Blood. 2021 Mar 11;137(10):1283-1294. doi: 10.1182/blood.2019003808. Blood. 2021. PMID: 33512406 Free article. Review.
Warm autoimmune hemolytic anemia (wAIHA) is caused by increased erythrocyte destruction by immunoglobulin G (IgG) autoantibodies, with or without complement activation. ...The disease may be primary, drug induced, or associated with lymphoproliferative
Warm autoimmune hemolytic anemia (wAIHA) is caused by increased erythrocyte destruction by immunoglobulin G (IgG
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis.
Scheckel CJ, Go RS. Scheckel CJ, et al. Hematol Oncol Clin North Am. 2022 Apr;36(2):315-324. doi: 10.1016/j.hoc.2021.12.001. Epub 2022 Mar 11. Hematol Oncol Clin North Am. 2022. PMID: 35282951 Review.
The causes of hemolytic anemia are numerous and a systematic approach is critical for proper identification and classification. The direct antiglobulin test can establish the diagnosis and subclassify the majority of autoimmune hemolytic anemias. Furth …
The causes of hemolytic anemia are numerous and a systematic approach is critical for proper identification and classification …
Warm Autoimmune Hemolytic Anemia.
Brodsky RA. Brodsky RA. N Engl J Med. 2019 Aug 15;381(7):647-654. doi: 10.1056/NEJMcp1900554. N Engl J Med. 2019. PMID: 31412178 Review. No abstract available.
Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting.
Jäger U, Barcellini W, Broome CM, Gertz MA, Hill A, Hill QA, Jilma B, Kuter DJ, Michel M, Montillo M, Röth A, Zeerleder SS, Berentsen S. Jäger U, et al. Blood Rev. 2020 May;41:100648. doi: 10.1016/j.blre.2019.100648. Epub 2019 Dec 5. Blood Rev. 2020. PMID: 31839434 Review.
Autoimmune hemolytic anemias (AIHAs) are rare and heterogeneous disorders characterized by the destruction of red blood cells through warm or cold antibodies. ...Corticosteroids remain first-line therapy for warm-AIHA, while the addition of rituximab s
Autoimmune hemolytic anemias (AIHAs) are rare and heterogeneous disorders characterized by the destruction of red blood cells
Autoimmune hemolytic anemia.
Hill A, Hill QA. Hill A, et al. Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):382-389. doi: 10.1182/asheducation-2018.1.382. Hematology Am Soc Hematol Educ Program. 2018. PMID: 30504336 Free PMC article. Review.
The diagnosis of autoimmune hemolytic anemia (AIHA) can be made with a stepwise approach that aims to identify laboratory and clinical evidence of hemolysis and then determine the immune nature of hemolysis with the direct anti-globulin test. ...Rituximab is …
The diagnosis of autoimmune hemolytic anemia (AIHA) can be made with a stepwise approach that aims to identify laborato …
Warm autoimmune hemolytic anemia: new insights and hypotheses.
Branch DR. Branch DR. Curr Opin Hematol. 2023 Nov 1;30(6):203-209. doi: 10.1097/MOH.0000000000000779. Epub 2023 Jul 27. Curr Opin Hematol. 2023. PMID: 37497853 Free PMC article. Review.
PURPOSE OF REVIEW: Warm autoimmune hemolytic anemia (wAIHA) is the most common of the immune hemolytic anemias. ...This review will provide insight into the common specificity of the warm autoantibodies and hypothesize a novel mechanism o …
PURPOSE OF REVIEW: Warm autoimmune hemolytic anemia (wAIHA) is the most common of the immune hemolytic an …
Autoimmune Hemolytic Anemias: Classifications, Pathophysiology, Diagnoses and Management.
Loriamini M, Cserti-Gazdewich C, Branch DR. Loriamini M, et al. Int J Mol Sci. 2024 Apr 12;25(8):4296. doi: 10.3390/ijms25084296. Int J Mol Sci. 2024. PMID: 38673882 Free PMC article. Review.
Autoimmune hemolytic anemias (AIHAs) are conditions involving the production of antibodies against one's own red blood cells (RBCs). ...Although usually self-remitting, management may consider monoclonal antibodies to C1q or C5. (5) Direct antiglobulin test-negative
Autoimmune hemolytic anemias (AIHAs) are conditions involving the production of antibodies against one's own red blood cells (
Autoimmune hemolytic anemia.
Gehrs BC, Friedberg RC. Gehrs BC, et al. Am J Hematol. 2002 Apr;69(4):258-71. doi: 10.1002/ajh.10062. Am J Hematol. 2002. PMID: 11921020 Free article. Review.
Red blood cell (RBC) autoantibodies are a relatively uncommon cause of anemia. However, autoimmune hemolytic anemia (AIHA) must be considered in the differential diagnosis of hemolytic anemias, especially if the patient has a concomitant lymphop …
Red blood cell (RBC) autoantibodies are a relatively uncommon cause of anemia. However, autoimmune hemolytic anemia
Severe autoimmune hemolytic anemia; epidemiology, clinical management, outcomes and knowledge gaps.
Mulder FVM, Evers D, de Haas M, Cruijsen MJ, Bernelot Moens SJ, Barcellini W, Fattizzo B, Vos JMI. Mulder FVM, et al. Front Immunol. 2023 Sep 18;14:1228142. doi: 10.3389/fimmu.2023.1228142. eCollection 2023. Front Immunol. 2023. PMID: 37795092 Free PMC article. Review.
Autoimmune hemolytic anemia (AIHA) is an acquired hemolytic disorder, mediated by auto-antibodies, and has a variable clinical course ranging from fully compensated low grade hemolysis to severe life-threatening cases. ...There are no validated predict
Autoimmune hemolytic anemia (AIHA) is an acquired hemolytic disorder, mediated by auto-antibodies, and has a var
Autoimmune Hemolytic Anemia in Children: Laboratory Investigation, Disease Associations, and Treatment Strategies.
Blackall D, Dolatshahi L. Blackall D, et al. J Pediatr Hematol Oncol. 2022 Apr 1;44(3):71-78. doi: 10.1097/MPH.0000000000002438. J Pediatr Hematol Oncol. 2022. PMID: 35235549 Review.
Autoimmune hemolytic anemia is a relatively uncommon pediatric clinical condition. As such, the evaluation and management of these cases can be challenging for even the most seasoned pediatrician. In this review, the 3 major forms of autoimmune hemo
Autoimmune hemolytic anemia is a relatively uncommon pediatric clinical condition. As such, the evaluation and manageme
863 results